Rafferty Asset Management, LLC
Position in KYMR — Kymera Therapeutics, Inc.
CIK 1389426
New York, NY
Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,046,360
-$562,158 QoQ
Shares Held
35,287
-36.2% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#98
of 273 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. KYMR ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
This page
|
35,287 | $4,046,360 |
All Filings in KYMR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,046,360 | 35,287 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,608,518 | 55,331 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,563,789 | 58,653 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,865,497 | 68,295 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,751,622 | 40,138 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,614,337 | 58,982 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,288,201 | 56,878 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,097,795 | 65,451 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,710,977 | 90,820 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,476,612 | 210,861 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,060,011 | 120,189 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,086,376 | 150,099 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,931,125 | 214,490 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,195,307 | 209,089 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,380,752 | 215,575 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,910,806 | 179,642 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,960,174 | 150,339 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,253,096 | 124,128 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,080,818 | 95,776 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,746,036 | 46,749 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,502,648 | 51,601 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,013,336 | 51,810 | Shares | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||